ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,304.72
      0.70%
      US Tech 100
      18,318.00
      0.95%
      Dow Jones
      39,069.59
      0.01%
      Brent Oil
      81.965
      0.00%
      Bitcoin
      68,826.95
      -0.64%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. bioAffinity Technologies Inc (BIAFW)

      7. bioAffinity Technologies Inc (BIAFW) News

      BIAFW

      bioAffinity Technologies (BIAFW)

      bioAffinity Technologies Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:BIAFW
      DateTimeSourceHeadlineSymbolCompany
      05/22/20244:00PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BIAFWbioAffinity Technologies Inc
      05/22/20244:00PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BIAFWbioAffinity Technologies Inc
      05/15/202410:53AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIAFWbioAffinity Technologies Inc
      05/15/20249:15AMBusiness WirebioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory VolumesNASDAQ:BIAFWbioAffinity Technologies Inc
      05/02/20248:00AMBusiness WirebioAffinity Technologies News UpdateNASDAQ:BIAFWbioAffinity Technologies Inc
      04/24/20248:00AMBusiness WirebioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of GrowthNASDAQ:BIAFWbioAffinity Technologies Inc
      04/09/20248:00AMBusiness WirebioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer ScreeningNASDAQ:BIAFWbioAffinity Technologies Inc
      04/01/20249:49AMBusiness WirebioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:BIAFWbioAffinity Technologies Inc
      03/08/202412:45PMBusiness WirebioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFWbioAffinity Technologies Inc
      03/06/20249:46AMBusiness WirebioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFWbioAffinity Technologies Inc
      02/21/20248:00AMBusiness WirebioAffinity Technologies News UpdateNASDAQ:BIAFWbioAffinity Technologies Inc
      01/30/20248:00AMBusiness WirebioAffinity Technologies In The NewsNASDAQ:BIAFWbioAffinity Technologies Inc
      01/08/20248:00AMBusiness WirebioAffinity Technologies In the NewsNASDAQ:BIAFWbioAffinity Technologies Inc
      12/05/20238:00AMBusiness WirebioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of DirectorsNASDAQ:BIAFWbioAffinity Technologies Inc
      11/30/20238:00AMBusiness WireCMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024NASDAQ:BIAFWbioAffinity Technologies Inc
      11/28/20238:00AMBusiness WirebioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology PostNASDAQ:BIAFWbioAffinity Technologies Inc
      11/14/20234:01PMBusiness WirebioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:BIAFWbioAffinity Technologies Inc
      11/06/20238:00AMBusiness WirebioAffinity Technologies Names Dallas J. Coleman as National Director of SalesNASDAQ:BIAFWbioAffinity Technologies Inc
      10/10/20238:00AMBusiness WirebioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth ConferenceNASDAQ:BIAFWbioAffinity Technologies Inc
      09/07/20238:00AMBusiness WirebioAffinity Technologies to Participate in the H.C. Wainwright Global Investment ConferenceNASDAQ:BIAFWbioAffinity Technologies Inc
      08/14/20235:03PMBusiness WirebioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:BIAFWbioAffinity Technologies Inc
      07/12/20238:00AMBusiness WireAMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung CancerNASDAQ:BIAFWbioAffinity Technologies Inc
      06/15/20238:00AMBusiness WirebioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics SymposiumNASDAQ:BIAFWbioAffinity Technologies Inc
      05/22/20238:00AMBusiness WirebioAffinity Technologies Presents Research Findings at CYTO 2023NASDAQ:BIAFWbioAffinity Technologies Inc
      05/01/20238:00AMBusiness WirebioAffinity Technologies Names Michael Dougherty as Chief Financial OfficerNASDAQ:BIAFWbioAffinity Technologies Inc
      04/25/20238:00AMBusiness WirebioAffinity Technologies Presents at Cleveland Clinic Lung Cancer SymposiumNASDAQ:BIAFWbioAffinity Technologies Inc
      03/31/20235:52PMBusiness WirebioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial ResultsNASDAQ:BIAFWbioAffinity Technologies Inc
       Showing the most relevant articles for your search:NASDAQ:BIAFW